Our job at SC MAT ACCESS is to facilitate your access to training. In addition to the training resources listed above, our team of experts is offering a series of in-person waiver trainings. These trainings will be free of charge and open to any waiver-eligible provider. To register, Contact Us. A list of upcoming trainings is provided below:
South Carolina is in the midst of an opioid epidemic. From addiction to overdose, the impact of opioid abuse is far reaching and can be devastating.
If you are an active primary care provider in South Carolina, there is a reasonable likelihood that the opioid epidemic has touched the lives of one or more of your patients.
Becoming a MAT provider does not have to mean refocusing your practice into a drug treatment facility. What it does mean is that you will be trained, equipped, and ready to offer evidence-based treatment options to your patients who may be struggling with opioid addiction.
Providing MAT can be a cost-effective addition to the existing array of services you provide your patients.
Witnessing the life-saving effects that this evidence-based treatment for opioid addiction can have in the lives of your patients can be the biggest benefit of all.
Currently, three provider classes are eligible to become DATA 2000 waivered to prescribe buprenorphine in the context of MAT. Click below for more information regarding eligibility and training requirements for each:
Under the Drug Addiction Treatment Act of 2000 (DATA 2000), qualified physicians may apply for waivers to treat opioid dependency with approved buprenorphine products in any settings in which they are qualified to practice, including a office, community hospital, health department, or correctional facility.
The Comprehensive Addiction and Recovery Act (CARA) wassigned into law in July, 2016. One of CARA’s provisions was to expand access to MAT by extending the privilege of prescribing buprenorphine in office-based settings to qualifying nurse practitioners (NPs) and physician assistants (PAs) until October 1, 2021.
Once SAMHSA verifies that the background of a provider is correct and valid, the DEA assigns the waivered provider a special identification number. DEA regulations require this identification number and the provider’s regular DEA registration number on all buprenorphine prescriptions for opioid dependence treatment.
Several resources exist to help providers access the training required for DATA 2000/CARA eligibility. We have summarized these training opportunities in the table below. You can visit the website for any one of these training programs by clicking the training title on the left-hand column of the table.
|Americans Academy of Addiction Psychiatry - CURRENTLY UNAVAILABLE DUE TO UPDATING||8 AMA PRA Category 1||MD, DO|
|ASAM Buprenorphine Course for Office-Based Treatment of Opioid Use Disorders||None for Online/Live Varies||Live In-Person & Web-Based||8/Additional 16||8 AMA PRA Category 1 orup to 24 AAPA Category 1 orup to 24 AANP CE||MD, DO, NP, PA|
|Providers Clinical Support System for Medication Assisted Treatment Self-Study at the American Osteopathic Academy of Addiction Medicine||None||Live Online & Web-Based||8||4.25 -8 AMA PRA Category 1/ 8 AAFP/ 8 AOA Category 1-A||MD, DO, NP, PA|
|Providers’ Clinical Support System for Medication Assisted Treatment||None||Live & Web-Based||8/Additional 16||8 AMA PRA Category 1||MD, DO, NP, PA|
Once you have completed your waiver training, registered with SAMHSA, and received your DEA special identification number, you are ready to begin seeing patients. Patient limits can be increased annually through completion of a brief additional application process. Yearly patient limits are as follows: